Kenneth Tew to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Kenneth Tew has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.063
-
TLK-286: a novel glutathione S-transferase-activated prodrug. Expert Opin Investig Drugs. 2005 Aug; 14(8):1047-54.
Score: 0.063
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.